Blog

/Blog

3rd Annual SAPA-CT Conference in New Haven

CURE member organization The Sino-American Pharmaceutical Professionals Association Connecticut (SAPA-CT) had its third annual conference in New Haven on Saturday, this past weekend on "Bringing Value to Patients through Technology Advancements and Global Innovations.  Of the almost 400 participants, many members of the CURE organization were on the scene - Alexion, Boehringer Ingelheim, Yale, HLK, University of New Haven, Quinnipiac University, and Dilworth, IP  to name a few. Two distinguished speakers led off the morning session.  The first speaker was Henry C. Lee, famed Professor in Forensic Science of the University of New Haven.  Professor Lee gave a fascinating and [...]

By |October 11th, 2016|Blog|0 Comments

Biosimilars – White Paper

The White Paper below discusses Sathguru's estimate of the global biosimilars market size in 2030 being USD 240Bn and the current landscape with a particular emphasis on critical challenges that need to be addressed to actualize the opportunity. Sathguru has wealth of experience and knowledge on biologics across strategy, M&A and innovation partnerships. For any comments or discussions, please reach out to the authors at pushpa@sathguru.com or lifesciences@sathguru.com http://www.sathguru.com/Publication/download/Biosimilars-WhitePaper-report.pdf

By |October 11th, 2016|Blog|0 Comments

Aetna Prizes in Technology and Health

Aetna Foundation Prize for Health Equity Innovation Seed Stage Grants ($10,000) With the support of the Aetna Foundation, InnovateHealth Yale, a program at the Yale School of Public Health, will award two $10,000 seed awards to develop technological solutions to address health challenges that disproportionately impact low-income communities. Solutions which employ mobile technology are actively encouraged, but the prize is open to any proposed improvement involving a technological solution. The Aetna Foundation Seed Stage Grant is open to both Yale students and students from any college or university in Connecticut. One seed award will be given to a team of [...]

By |September 26th, 2016|Blog|0 Comments

YEAR IN REVIEW: HOW CURE INNOVATION COMMONS IS LEADING CT’S BIOSCIENCE SCENE

While Connecticut’s startup community continues to will its way into the public eye, one bioscience cluster in Groton is singlehandedly thrusting the state into the national conversation. The organization, CURE, provides its members with the resources to create, innovate and network with partnering government agencies, mentors, investors, educators, scientists and entrepreneurs. Around this time last year, we profiled CURE. Earlier this week, we caught up with President and CEO Susan Froshauer to learn about the progress they have made over the last year. Taking Connecticut Innovation Nationally CURE represented Connecticut last month at the 2016 BIO International Conference in San [...]

By |August 5th, 2016|Blog|0 Comments

How to get a Top-tier Media Outlet to Cover your Organization

You want to see a positive story about your organization in a prestigious media outlet. You may need the coverage to attract investors or clients, or to build your board and employees’ confidence in your mission and goals. A press release will do the trick if you have discovered a cure for cancer or the fountain of youth. In fact, if your company is publicly traded, you will be required to issue a press release in either of those circumstances to give all investors equal access to such valuable information. But, what if you don’t have ground-breaking news to announce? [...]

By |August 1st, 2016|Blog|0 Comments

Developments in securities class actions brought against life sciences companies in 2015

Bellow is a recent report from Sidley Austin addressing developments in securities class actions brought against life sciences companies in 2015. The report begins with an overview of decisions involving life sciences companies, provides summaries of the 34 federal district court and appellate court decisions, and catalogs the new securities class action complaints filed against life sciences companies in 2015. View Report Here

By |July 19th, 2016|Blog|0 Comments

LEGISLATIVE UPDATE: NEW LAWS AFFECTING CONNECTICUT EMPLOYERS

As the most recent legislative session came to an end, Governor Malloy signed into law several bills passed by the General Assembly that are of significance to Connecticut employers: Connecticut has become the most recent state to join the "Ban the Box" movement. Effective January 1, 2017, Public Act 16-83 prohibits Connecticut employers with at least one employee from inquiring about a prospective employee's prior arrests, criminal charges or convictions on initial employment applications. The restriction does not apply where (i) state or federal law compels an employer to inquire about a candidate's criminal history, and (ii) a security or [...]

By |July 18th, 2016|Blog|0 Comments

Latest incubator creates CT’s ‘bioscience triangle’

Like the CEO of any startup, Wendy Davis understands the challenges of taking a fledgling company and trying to grow it. That's perhaps doubly true in the bioscience industry where access to affordable lab space and equipment are often essential to success. "Science-based [startups] have unique needs," said Davis, whose company is working to commercialize a diagnostic for preeclampsia, a potentially life threatening complication of pregnancy. "They need an environment so they don't get bogged down in day-to-day support infrastructure [concerns] that can detract from accomplishing significant milestones." Davis, it seems, has found her company's home: Groton-based CURE Innovation Commons, [...]

By |July 5th, 2016|Blog|0 Comments

Front & Center Interview with Dr. Susan Froshauer [6.15.16]

Connecticut's bioscience industry is growing. Listen to Dan Lovallo's "Front & Center" radio interview with Dr. Susan Froshauer, President and CEO of CURE, Connecticut's bioscience cluster, discussing how this field is expanding in the state.  

By |June 23rd, 2016|Blog|0 Comments

The Emergent Microbiome: A Revolution for the Life Sciences – Part VI, Diagnostics

This is the sixth installment in a series on advancements in microbiome research and development. Our goal with this series is to inform readers about developments in this important field. Previous articles have reviewed efforts to manipulate the microbiome to treat disease, and this installment will discuss developments in diagnostics that utilize the microbiome. This article will also explore the significant patent challenges for this nascent area of microbiome-based diagnostics, particularly in view of current patent litigation that is likely to make it to the Supreme Court next term. Previous editions from this series of articles can be found at the [...]

By |May 27th, 2016|Blog|0 Comments